APA Citatie

Imel, E., Whyte, M., Munns, C., Portale, A., Ward, L., Nilsson, O., . . . Glorieux, F. (2019). OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH). J Endocr Soc.

Chicago Style citaat

Imel, Erik, et al. "OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional Therapy in Children With X-Linked Hypophosphatemia (XLH)." J Endocr Soc 2019.

MLA citatie

Imel, Erik, et al. "OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional Therapy in Children With X-Linked Hypophosphatemia (XLH)." J Endocr Soc 2019.